Skip to main content
. Author manuscript; available in PMC: 2018 Jan 15.
Published in final edited form as: Adv Drug Deliv Rev. 2016 Dec 3;109:26–44. doi: 10.1016/j.addr.2016.11.006

Figure 14.

Figure 14

Passively scattered proton therapy dose distributions for a non-small cell lung cancer (NSCLC) patient computed with (a) Monte Carlo simulations and (b) a conventional commercial treatment planning system (TPS). Panel (c) shows the TPS – MC difference dose distribution, illustrating the under-dosing in conventional model predictions. Similarly the difference MC – TPS (not shown) would illustrate regions of over-dosing. (Mirkovic, et al. Unpublished, private communication)